Cargando…

Severe T2-high asthma in the biologics era: European experts' opinion

The European Respiratory Biologics Forum gathered participants from 21 countries in Madrid, Spain, to discuss the management and treatment of severe asthma in the era of biologics. The current insights on the pathophysiology of severe asthma were discussed, as well as the role of respiratory biologi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pavord, Ian, Bahmer, Thomas, Braido, Fulvio, Cosío, Borja G., Humbert, Marc, Idzko, Marco, Adamek, Lukasz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489011/ https://www.ncbi.nlm.nih.gov/pubmed/31285291 http://dx.doi.org/10.1183/16000617.0054-2019

Ejemplares similares

Failure in Asthma Control: Reasons and Consequences
por: Braido, Fulvio
Publicado: (2013)

Current expert opinion and attitudes to optimize telemedicine and achieve control in patients with asthma in post-pandemic era: The COMETA consensus
por: Molina Paris, Jesús, et al.
Publicado: (2022)

Patients beliefs on intravenous and subcutaneous routes of administration of biologics for severe asthma treatment: A cross-sectional observational survey study
por: Santus, Pierachille, et al.
Publicado: (2019)

Experts Opinion
por: Goldberg, Ivan, et al.
Publicado: (2012)

Expert Opinion
Publicado: (1920)

Minimal clinically important difference for asthma endpoints: an expert consensus report
por: Bonini, Matteo, et al.
Publicado: (2020)

Psychological aspects in asthma: do psychological factors affect asthma management?
por: Baiardini, Ilaria, et al.
Publicado: (2015)

Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion
por: Donders, Gilbert, et al.
Publicado: (2022)

More Expert Opinion
Publicado: (1920)

Evaluation and Management of Difficult-to-Treat and Severe Asthma: An Expert Opinion From the Korean Academy of Asthma, Allergy and Clinical Immunology, the Working Group on Severe Asthma
por: Kim, Byung-Keun, et al.
Publicado: (2020)

Defining severe obstructive lung disease in the biologic era: an endotype-based approach
por: Martin, Richard J., et al.
Publicado: (2019)

Nonadherence in the era of severe asthma biologics and thermoplasty
por: Lee, Joy, et al.
Publicado: (2018)

Severe Asthma in the Era of Biologics: Continuous Challenges
por: Schoini, Pinelopi, et al.
Publicado: (2023)

Type 2 inflammation and biological therapies in asthma: Targeted medicine taking flight
por: Howell, Imran, et al.
Publicado: (2023)

Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era
por: Jackson, David J, et al.
Publicado: (2021)

Patellofemoral arthroplasty: expert opinion
por: Hoogervorst, Paul, et al.
Publicado: (2022)

InternationaL cross-sectIonAl and longItudinal assessment on aSthma cONtrol in European adult patients - the LIAISON study protocol
por: Braido, Fulvio, et al.
Publicado: (2013)

International expert opinion on the use of nebulization for pediatric asthma therapy during the COVID-19 pandemic
por: Shen, Kunling, et al.
Publicado: (2021)

Expert Opinion on Biological Treatment of Chronic Rhinosinusitis with Nasal Polyps in the Gulf Region
por: Al-Ahmad, Mona, et al.
Publicado: (2022)

How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion
por: Sarzi-Puttini, Piercarlo, et al.
Publicado: (2020)

Beliefs and preferences regarding biological treatments for severe asthma
por: Bikov, Andras, et al.
Publicado: (2020)

When expert opinion does matter...
por: Delmo Walter, E M, et al.
Publicado: (2012)

Expert opinion about osteonecrosis of the jaw
por: Lee, Jeong Keun
Publicado: (2017)

Management of Osteoarthritis: Expert Opinion on NSAIDs
por: Magni, Alberto, et al.
Publicado: (2021)

Editorial: Experts' opinion in medicine 2022
por: Bunik, Victoria I.
Publicado: (2023)

Navigating adalimumab biosimilars: an expert opinion
por: Abitbol, Vered, et al.
Publicado: (2023)

Daily, Once-Weekly, or No Asthma Controller Therapy At All: The Annoying Issue with Disease Remission in Clinical Asthma Trials
por: Bahmer, Thomas
Publicado: (2021)

The Response to Biologics is Better in Patients with Severe Asthma Than in Patients with Asthma–COPD Overlap Syndrome
por: Pérez de Llano, Luis, et al.
Publicado: (2022)

Chronic obstructive lung disease “expert system”: validation of a predictive tool for assisting diagnosis
por: Braido, Fulvio, et al.
Publicado: (2018)

Asthma–COPD overlap: identification and optimal treatment
por: Cosío, Borja G., et al.
Publicado: (2018)

Asthma-COPD overlap is not a homogeneous disorder: further supporting data
por: Pérez-de-Llano, Luis, et al.
Publicado: (2017)

Expert opinion as 'validation' of risk assessment applied to calf welfare
por: Bracke, Marc BM, et al.
Publicado: (2008)

Asthma in the Precision Medicine Era: Biologics and Probiotics
por: Chiu, Chiao-Juno, et al.
Publicado: (2021)

Revenue assurance : expert opinions for communications providers
por: Priezkalns, Eric, et al.
Publicado: (2011)

Benefits of genome-edited crops: expert opinion
por: Lassoued, Rim, et al.
Publicado: (2019)

Placebo effects in allergen immunotherapy: an experts’ opinion
por: Frew, Anthony J., et al.
Publicado: (2018)

Heart Rate in Hypertension: Review and Expert Opinion
por: Dalal, Jamshed, et al.
Publicado: (2019)

Expert opinions on immunotherapy for patients with colorectal cancer
por: Wang, Feng, et al.
Publicado: (2020)

Expert opinions on the regulation of plant genome editing
por: Lassoued, Rim, et al.
Publicado: (2021)

Opinion-Based Recommendations: Beware the Tyranny of Experts
por: Spellberg, Brad, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v1c8sultrgv0ncd6b6j3r80acu